New treatment aims to spare patients from Voice-Box removal surgery
NCT ID NCT07423078
Summary
This trial is testing a combination of chemotherapy and immunotherapy drugs (carboplatin/cisplatin, paclitaxel, and toripalimab) for adults with advanced throat cancer. The main goal is to see if this treatment can effectively control the cancer while allowing patients to keep their voice box, avoiding a life-altering surgery called a total laryngectomy. Researchers will enroll about 87 patients to measure survival rates, safety, and how many patients successfully preserve their larynx.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPOPHARYNGEAL SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UPMC Hillman Cancer
Pittsburgh, Pennsylvania, 15213, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.